• 1
    van der Werf MJ, de Vlas SJ, Brooker S et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003; 86: 12539
  • 2
    Young ND, Jex AR, Li B et al. Whole-genome sequence of Schistosoma haematobium. Nat Genet 2012; 44: 2215
  • 3
    Ordan P, Goatly KD. Experimental schistosomiasis in primates in Tanzania. I. A preliminary note on the susceptibility of Cercopithecus aethiops centralis to infection with Schistosoma haematobium and Schistosoma mansoni. Ann Trop Med Parasitol 1966; 60: 39
  • 4
    Kuntz RE, Malakatis GM. Susceptibility studies in schistosomiasis. IV. Susceptibility of wild mammals to infection by Schistosoma haematobium in Egypt, with emphasis on rodents. J Parasitol 1955; 41: 46775
  • 5
    Vuong PN, Bayssade-Dufour C, Albaret JL, Farhati K. Histopathological observations in new and classic models of experimental Schistosoma haematobium infections. Trop Med Int Health 1996; 1: 34858
  • 6
    Fu CL, Odegaard JI, Herbert DR, Hsieh MH. A novel mouse model of Schistosoma haematobium egg-induced immunopathology. Plos Pathog 2012; 8: e1002605
  • 7
    Forsyth DM, Bradley DJ. Irreversible damage by Schistosoma haematobium in schoolchildren. Lancet 1964; 2: 16971
  • 8
    Abdel-Wahab MF, Ramzy I, Esmat G, El Kafass H, Strickland GT. Ultrasound for detecting Schistosoma haematobium urinary tract complications: comparison with radiographic procedures. J Urol 1992; 148: 34650
  • 9
    Doehring E, Ehrich JH, Bremer HJ. Reversibility of urinary tract abnormalities due to Schistosoma haematobium infection. Kidney Int 1986; 30: 5825